8-K Announcements
6Material company update
Mar 26, 2026·SEC
Material company update
Feb 25, 2026·SEC
Material company update
Jan 12, 2026·SEC
Geron Corporation(GERN)Earnings, Financials & Key Ratios
GERN•NASDAQ
Price updated Jun 19, 2026
AboutGeron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.Show more
- Revenue$184M+138.8%
- EBITDA-$53M+69.5%
- Net Income-$86M+50.9%
- EPS (Diluted)-0.13+51.9%
- Gross Margin97.42%-1.0%
- EBITDA Margin-28.62%+87.2%
- Operating Margin-29.28%+87.0%
- Net Margin-46.65%+79.4%
- ROE-33.89%+48.7%
GERN Key Insights
Geron Corporation (GERN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 273.5%
✗Weaknesses
- ✗Weak Piotroski F-Score: 2/9
- ✗Negative free cash flow
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when GERN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
GERN Price & Volume
Geron Corporation (GERN) stock price & volume — 10-year historical chart
Loading chart...
GERN Growth Metrics
Geron Corporation (GERN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years17.59%
5 Years273.49%
3 Years575.71%
TTM68.64%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM49.94%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM47.92%
Return on Capital
10 Years-45.84%
5 Years-60.09%
3 Years-50.69%
Last Year-11.16%
GERN Recent Earnings
Geron Corporation (GERN) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 6, 2026Metric
Actual
Est
EPS
$0.01+66.7%
$0.03
Rev
$52M+2.5%
$51M
Q1 2026
Feb 25, 2026Metric
Actual
Est
EPS
$0.03+0.0%
$0.03
Rev
$48M-4.8%
$50M
Q4 2025
Nov 5, 2025Metric
Actual
Est
EPS
$0.03+18.2%
$0.04
Rev
$47M-11.5%
$53M
Q3 2025
Aug 6, 2025Metric
Actual
Est
EPS
$0.02+33.3%
$0.03
Rev
$49M+3.7%
$47M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $0.01vs $0.03+66.7% | $52Mvs $51M+2.5% |
| Q1 2026 | Feb 25, 2026 | $0.03vs $0.03+0.0% | $48Mvs $50M-4.8% |
| Q4 2025 | Nov 5, 2025 | $0.03vs $0.04+18.2% | $47Mvs $53M-11.5% |
| Q3 2025 | Aug 6, 2025 | $0.02vs $0.03+33.3% | $49Mvs $47M+3.7% |
Based on last 12 quarters of dataView full earnings history →
GERN Peer Comparison
Geron Corporation (GERN) competitors in Oncology Therapeutics Developers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 IMVT | 7.26B | 35.34 | -12.76 | -68.16% | 0.00 | |||
 KYMR | 7.38B | 90.43 | -24.51 | -16.72% | -6.12% | -25.02% | 0.05 | |
 PTCT | 6.55B | 78.98 | 10.15 | 114.51% | -22.58% | |||
 TGTX | 8.15B | 53.22 | 19.21 | 87.32% | 65.95% | 87.36% | 0.40 | |
 ALLO | 487.74M | 2.00 | -2.30 | -100% | -56.45% | 0.26 | ||
 PRTA | 467.51M | 8.93 | -1.97 | -92.84% | -260.92% | -49.88% | 0.05 | |
 JAZZ | 14.09B | 224.66 | -38.47 | 4.88% | 0.66% | 0.71% | 1.26 | |
 SRPT | 1.85B | 17.53 | -2.46 | 15.58% | 2.98% | 4.89% | 0.91 |
Compare GERN vs Peers
Geron Corporation (GERN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
GERN Income Statement
Geron Corporation (GERN) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 1.06M | 1.07M | 460K | 253K | 1.39M | 596K | 237K | 76.99M | 183.88M | 196.12M |
Revenue Growth % | -82.72% | 0.09% | -56.85% | -45% | 450.59% | -57.21% | -60.23% | 32386.92% | 138.83% | 68.64% |
Cost of Goods Sold | 8.44M | 12.72M | 51.27M | 50.05M | 0 | 0 | 0 | 1.26M | 4.75M | 24.61M |
COGS % of Revenue | 792.21% | 1193.53% | 11146.09% | 19783.4% | - | - | - | 1.63% | 2.58% | - |
Gross Profit | -7.37M▲ 0% | -11.66M▼ 58.1% | -50.81M▼ 335.9% | -49.8M▲ 2.0% | 1.39M▲ 102.8% | 596K▼ 57.2% | 237K▼ 60.2% | 75.74M▲ 31857.0% | 179.14M▲ 136.5% | 119.67M▲ 0% |
Gross Margin % | -692.21% | -1093.53% | -11046.09% | -19683.4% | 100% | 100% | 100% | 98.37% | 97.42% | 61.02% |
Gross Profit Growth % | 13.61% | -58.13% | -335.89% | 1.99% | 102.8% | -57.21% | -60.23% | 31856.96% | 136.52% | - |
Operating Expenses | 30.32M | 32.14M | 21.69M | 27.11M | 115.39M | 139.15M | 194.18M | 249.47M | 232.97M | 207.18M |
OpEx % of Revenue | 2846.95% | 3014.92% | 4715.87% | 10717% | 8283.7% | 23346.64% | 81932.91% | 324.01% | 126.7% | - |
Selling, General & Admin | 19.29M | 18.71M | 21.69M | 27.11M | 29.66M | 43.63M | 69.14M | 145.73M | 159.26M | 154.66M |
SG&A % of Revenue | 1810.99% | 1754.88% | 4715.87% | 10717% | 2129.58% | 7320.13% | 29170.89% | 189.28% | 86.61% | - |
Research & Development | 11.03M | 13.43M | 52.07M | 51.49M | 85.73M | 95.52M | 125.05M | 103.74M | 73.72M | 73.59M |
R&D % of Revenue | 1035.96% | 1260.04% | 11320% | 20350.99% | 6154.13% | 16026.51% | 52762.03% | 134.74% | 40.09% | - |
Other Operating Expenses | 0 | -154K | -52.07M | -51.49M | 0 | 0 | 0 | 0 | 0 | -1000K |
Operating Income | -29.25M▲ 0% | -31.07M▼ 6.2% | -72.5M▼ 133.3% | -76.91M▼ 6.1% | -114M▼ 48.2% | -138.55M▼ 21.5% | -193.94M▼ 40.0% | -173.73M▲ 10.4% | -53.84M▲ 69.0% | -36.97M▲ 0% |
Operating Margin % | -2746.95% | -2914.92% | -15761.96% | -30400.4% | -8183.7% | -23246.64% | -81832.91% | -225.64% | -29.28% | -18.85% |
Operating Income Growth % | 4.54% | -6.21% | -133.34% | -6.08% | -48.22% | -21.54% | -39.98% | 10.42% | 69.01% | - |
EBITDA | -29.18M | -31.01M | -72.44M | -76.75M | -113.22M | -137.68M | -192.91M | -172.51M | -52.63M | -36.26M |
EBITDA Margin % | -2739.81% | -2909.38% | -15748.04% | -30337.94% | -8127.49% | -23101.01% | -81397.05% | -224.06% | -28.62% | -18.49% |
EBITDA Growth % | 4.53% | -6.29% | -133.58% | -5.96% | -47.5% | -21.61% | -40.11% | 10.57% | 69.49% | 72.75% |
D&A (Non-Cash Add-back) | 76K | 59K | 64K | 158K | 783K | 868K | 1.03M | 1.22M | 1.2M | 712K |
EBIT | -29.25M | -27.02M | -72.5M | -76.91M | -112.37M | -135.02M | -175.81M | -156.07M | -53.13M | -41.49M |
Net Interest Income | 1.42M | 3.25M | 4.22M | 1.07M | -3.21M | -4.35M | 9.84M | 1.1M | -14.54M | -11.49M |
Interest Income | 1.42M | 3.25M | 4.22M | 1.83M | 527K | 2.53M | 18.15M | 19.61M | 18.12M | 16.38M |
Interest Expense | 0 | 0 | 0 | 760K | 3.74M | 6.88M | 8.31M | 18.5M | 32.66M | 17.31M |
Other Income/Expense | 1.34M | 4.06M | 3.96M | 1.3M | -2.11M | -3.35M | 9.82M | -840K | -31.95M | -32.62M |
Pretax Income | -27.92M▲ 0% | -27.02M▲ 3.2% | -68.55M▼ 153.7% | -75.62M▼ 10.3% | -116.11M▼ 53.6% | -141.9M▼ 22.2% | -184.13M▼ 29.8% | -174.57M▲ 5.2% | -85.78M▲ 50.9% | -69.59M▲ 0% |
Pretax Margin % | -2621.22% | -2534.43% | -14901.74% | -29888.14% | -8335.39% | -23808.89% | -77690.72% | -226.73% | -46.65% | -35.48% |
Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Net Income | -27.92M▲ 0% | -27.02M▲ 3.2% | -68.55M▼ 153.7% | -75.62M▼ 10.3% | -116.11M▼ 53.6% | -141.9M▼ 22.2% | -184.13M▼ 29.8% | -174.57M▲ 5.2% | -85.78M▲ 50.9% | -69.59M▲ 0% |
Net Margin % | -2621.22% | -2534.43% | -14901.74% | -29888.14% | -8335.39% | -23808.89% | -77690.72% | -226.73% | -46.65% | -35.48% |
Net Income Growth % | 5.49% | 3.22% | -153.72% | -10.31% | -53.55% | -22.21% | -29.76% | 5.19% | 50.86% | 49.94% |
Net Income (Continuing) | -27.92M | -27.02M | -68.55M | -75.62M | -116.11M | -141.9M | -184.13M | -174.57M | -85.78M | -69.59M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.18▲ 0% | -0.15▲ 16.7% | -0.33▼ 120.0% | -0.28▲ 15.2% | -0.37▼ 32.1% | -0.37▲ 0.0% | -0.32▲ 13.5% | -0.27▲ 15.6% | -0.13▲ 51.9% | -0.10▲ 0% |
EPS Growth % | 5.26% | 16.67% | -120% | 15.15% | -32.14% | 0% | 13.51% | 15.63% | 51.85% | 47.92% |
EPS (Basic) | -0.18 | -0.15 | -0.33 | -0.28 | -0.37 | -0.37 | -0.32 | -0.27 | -0.13 | - |
Diluted Shares Outstanding | 159.22M | 176.5M | 190.16M | 271.46M | 327.63M | 380.78M | 570.65M | 646.03M | 666.66M | 669.38M |
Basic Shares Outstanding | 159.22M | 176.5M | 190.16M | 271.46M | 327.63M | 380.78M | 570.65M | 646.03M | 666.66M | 669.38M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
GERN Balance Sheet
Geron Corporation (GERN) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 95.97M | 166.06M | 141.61M | 199.86M | 187.21M | 180.25M | 341.35M | 490.99M | 520.27M | 498.53M |
Cash & Short-Term Investments | 94.95M | 163.56M | 139.32M | 196.28M | 183.72M | 172.75M | 333.7M | 406.57M | 359.8M | 314.29M |
Cash Only | 16.6M | 10.84M | 13.64M | 9.93M | 34.87M | 56.84M | 70.02M | 79.02M | 79.44M | 70.78M |
Short-Term Investments | 78.35M | 152.71M | 125.68M | 186.35M | 148.85M | 115.9M | 263.68M | 327.55M | 280.36M | 243.51M |
Accounts Receivable | 436K | 1.17M | 802K | 722K | 1.76M | 3.14M | 1.66M | 38.8M | 39.23M | 0 |
Days Sales Outstanding | 149.43 | 399.93 | 636.37 | 1.04K | 461.95 | 1.93K | 2.55K | 183.93 | 77.86 | 53.02 |
Inventory | -436K | -1.17M | 0 | 0 | 0 | 0 | 0 | 38.71M | 0 | 0 |
Days Inventory Outstanding | - | - | - | - | - | - | - | 11.25K | - | 610.14 |
Other Current Assets | 268K | 269K | 270K | 363K | 364K | 4.36M | 5.99M | 6.91M | 121.25M | 184.25M |
Total Non-Current Assets | 14.34M | 19.23M | 23.91M | 70.87M | 38.83M | 10.33M | 52.73M | 102.79M | 50.27M | 35.59M |
Property, Plant & Equipment | 102K | 59K | 2.9M | 5.95M | 5.38M | 4.94M | 4.73M | 4.19M | 884K | 1M |
Fixed Asset Turnover | 10.44x | 18.07x | 0.16x | 0.04x | 0.26x | 0.12x | 0.05x | 18.37x | 208.01x | 88.06x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 14.24M | 18.58M | 19.65M | 63.39M | 28.65M | 0 | 43.3M | 94.52M | 41.29M | 149.78M |
Other Non-Current Assets | 0 | 585K | 1.35M | 1.53M | 4.8M | 5.39M | 4.7M | 4.08M | 8.1M | 7.9M |
Total Assets | 110.31M▲ 0% | 185.28M▲ 68.0% | 165.52M▼ 10.7% | 270.73M▲ 63.6% | 226.03M▼ 16.5% | 190.57M▼ 15.7% | 394.08M▲ 106.8% | 593.78M▲ 50.7% | 570.54M▼ 3.9% | 534.12M▲ 0% |
Asset Turnover | 0.01x | 0.01x | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x | 0.13x | 0.32x | 0.35x |
Asset Growth % | -15.31% | 67.96% | -10.67% | 63.57% | -16.51% | -15.69% | 106.78% | 50.68% | -3.91% | 42.11% |
Total Current Liabilities | 6.52M | 7.55M | 28.16M | 30.94M | 45.52M | 76.69M | 108.07M | 88.3M | 111.54M | 73.57M |
Accounts Payable | 503K | 982K | 1.18M | 6.92M | 6.69M | 10.19M | 6.16M | 8.6M | 11.26M | 0 |
Days Payables Outstanding | 21.76 | 28.17 | 8.41 | 50.46 | - | - | - | 2.5K | 865.92 | 113.44 |
Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 20.95M | 46.89M | 0 | 18.45M | 0 |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 2.36M | 3.6M | 4.83M | 8.22M | 8.1M | 11.53M | 13.76M | 43.18M | 80.84M | 73.57M |
Current Ratio | 14.73x | 21.99x | 5.03x | 6.46x | 4.11x | 2.35x | 3.16x | 5.56x | 4.66x | 6.78x |
Quick Ratio | 14.80x | 22.15x | 5.03x | 6.46x | 4.11x | 2.35x | 3.16x | 5.12x | 4.66x | 6.78x |
Cash Conversion Cycle | - | - | - | - | - | - | - | 8.94K | - | 549.72 |
Total Non-Current Liabilities | 0 | 0 | 2.2M | 28.84M | 54.1M | 33.88M | 38.06M | 225.16M | 233.13M | 231.44M |
Long-Term Debt | 0 | 0 | 0 | 24.04M | 49.83M | 30.21M | 35.05M | 118.48M | 231.68M | 0 |
Capital Lease Obligations | 0 | 0 | 2.2M | 4.8M | 4.27M | 3.67M | 3.01M | 2.27M | 1.45M | 4.97M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 104.42M | 0 | 231.44M |
Total Liabilities | 6.52M | 7.55M | 30.36M | 59.78M | 99.62M | 110.58M | 146.13M | 313.46M | 344.67M | 305.01M |
Total Debt | 0 | 0 | 2.55M | 29.72M | 55M | 55.75M | 85.9M | 121.72M | 251.57M | 0 |
Net Debt | -16.6M | -10.84M | -11.09M | 19.79M | 20.13M | -1.09M | 15.88M | 42.7M | 172.13M | -70.78M |
Debt / Equity | - | - | 0.02x | 0.14x | 0.44x | 0.70x | 0.35x | 0.43x | 1.11x | 0.00x |
Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.00x |
Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | 1.95x |
Interest Coverage | - | - | - | -101.20x | -30.05x | -19.62x | -21.15x | -8.43x | -1.63x | -2.40x |
Total Equity | 103.8M▲ 0% | 177.73M▲ 71.2% | 135.16M▼ 24.0% | 210.95M▲ 56.1% | 126.42M▼ 40.1% | 80M▼ 36.7% | 247.95M▲ 209.9% | 280.32M▲ 13.1% | 225.87M▼ 19.4% | 229.11M▲ 0% |
Equity Growth % | -15.18% | 71.23% | -23.96% | 56.08% | -40.07% | -36.72% | 209.94% | 13.06% | -19.42% | -64.3% |
Book Value per Share | 0.65 | 1.01 | 0.71 | 0.78 | 0.39 | 0.21 | 0.43 | 0.43 | 0.34 | 0.34 |
Total Shareholders' Equity | 103.8M | 177.73M | 135.16M | 210.95M | 126.42M | 80M | 247.95M | 280.32M | 225.87M | 229.11M |
Common Stock | 160K | 186K | 200K | 310K | 324K | 390K | 545K | 606K | 640K | 0 |
Retained Earnings | -985.84M | -1.01B | -1.08B | -1.16B | -1.27B | -1.41B | -1.6B | -1.77B | -1.86B | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -207K | -183K | 132K | 78K | -173K | -219K | 185K | 261K | 269K | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GERN Cash Flow Statement
Geron Corporation (GERN) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -20.56M | -21.01M | -43.83M | -66.65M | -95.56M | -127.38M | -167.74M | -218.62M | -111.04M | -125.96M |
Operating CF Margin % | -1930.14% | -1970.83% | -9528.04% | -26344.66% | -6859.73% | -21372.32% | -70777.64% | -283.94% | -60.39% | - |
Operating CF Growth % | -11.91% | -2.2% | -108.62% | -52.07% | -43.37% | -33.3% | -31.69% | -30.33% | 49.21% | 144.38% |
Net Income | -27.92M | -27.02M | -68.55M | -75.62M | -116.11M | -141.9M | -184.13M | -174.57M | -85.78M | -69.59M |
Depreciation & Amortization | 76K | 59K | 776K | 935K | 783K | 868K | 1.03M | 1.22M | 1.2M | 1.22M |
Stock-Based Compensation | 8.14M | 6.37M | 6.08M | 6.89M | 8.08M | 8M | 19.35M | 31.32M | 88K | 6.82M |
Deferred Taxes | 310K | -365K | -1.33M | 488K | 191K | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 200K | 191K | 68K | 264K | 984K | 626K | -10.06M | -8.18M | 41.99M | 34.31M |
Working Capital Changes | -1.37M | -245K | 19.13M | 383K | 10.52M | 5.03M | 6.06M | -68.41M | -68.54M | -101M |
Change in Receivables | 39K | -528K | 366K | 80K | -1.04M | -1.38M | 1.49M | -36.89M | -377K | -9.92M |
Change in Inventory | 0 | 0 | -366K | -80K | 1.04M | 1.38M | 0 | -37.97M | -77.92M | -77.06M |
Change in Payables | 278K | 479K | 199K | 5.73M | -232K | 3.5M | -4.03M | 2.44M | 2.66M | 1.46M |
Cash from Investing | 22.97M | -77.72M | 27.4M | -105.32M | 71.95M | 62.07M | -180.32M | -106M | 107.25M | 106.66M |
Capital Expenditures | 0 | -16K | -413K | -401K | -207K | -431K | -830K | -680K | -49K | -333K |
CapEx % of Revenue | - | 1.5% | 89.78% | 158.5% | 14.86% | 72.32% | 350.21% | 0.88% | 0.03% | 0.17% |
Acquisitions | 0 | 0 | -27.81M | 339K | 1.59M | -1.23M | 179.49M | 0 | 0 | -64K |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 22.97M | -77.7M | 27.81M | -339K | -1.59M | 1.23M | -179.49M | 0 | 0 | 64K |
Cash from Financing | 1.11M | 92.97M | 19.5M | 168.35M | 48.56M | 87.26M | 362.02M | 334.37M | 2.27M | 4.44M |
Debt Issued (Net) | 0 | 0 | 0 | 23.86M | 24.89M | 0 | 29.7M | 34.57M | 0 | 0 |
Equity Issued (Net) | 1.06M | 86.02M | 19.3M | 144.26M | 20.39M | 69.92M | 213.34M | 140.73M | 2.27M | 4.44M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | 51K | 6.95M | 204K | 224K | 3.28M | 17.35M | 118.98M | 159.08M | 0 | 0 |
Net Change in Cash | 3.52M▲ 0% | -5.76M▼ 263.4% | 3.07M▲ 153.3% | -3.63M▼ 218.1% | 24.95M▲ 788.0% | 21.97M▼ 11.9% | 13.93M▼ 36.6% | 9.74M▼ 30.1% | -1.44M▼ 114.7% | -14.83M▲ 0% |
Free Cash Flow | -20.56M▲ 0% | -21.02M▼ 2.3% | -44.24M▼ 110.4% | -67.05M▼ 51.6% | -95.76M▼ 42.8% | -127.81M▼ 33.5% | -168.57M▼ 31.9% | -219.3M▼ 30.1% | -111.09M▲ 49.3% | -126.3M▲ 0% |
FCF Margin % | -1930.14% | -1972.33% | -9617.83% | -26503.16% | -6874.59% | -21444.63% | -71127.85% | -284.82% | -60.41% | -64.4% |
FCF Growth % | -11.56% | -2.28% | -110.43% | -51.56% | -42.82% | -33.46% | -31.89% | -30.09% | 49.34% | 38.21% |
FCF per Share | -0.13 | -0.12 | -0.23 | -0.25 | -0.29 | -0.34 | -0.30 | -0.34 | -0.17 | -0.19 |
FCF Conversion (FCF/Net Income) | 0.74x | 0.78x | 0.64x | 0.88x | 0.82x | 0.90x | 0.91x | 1.25x | 1.29x | 1.81x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GERN Key Ratios
Geron Corporation (GERN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -24.69% | -19.19% | -43.82% | -43.7% | -68.84% | -137.49% | -112.29% | -66.09% | -33.89% | -28.9% |
Return on Invested Capital (ROIC) | -22.33% | -18.34% | -37.38% | -32.52% | -45.32% | -92.18% | -84.88% | -44.41% | -11.2% | -9.62% |
Gross Margin | -692.21% | -1093.53% | -11046.09% | -19683.4% | 100% | 100% | 100% | 98.37% | 97.42% | 61.02% |
Net Margin | -2621.22% | -2534.43% | -14901.74% | -29888.14% | -8335.39% | -23808.89% | -77690.72% | -226.73% | -46.65% | -35.48% |
Debt / Equity | - | - | 0.02x | 0.14x | 0.44x | 0.70x | 0.35x | 0.43x | 1.11x | 0.00x |
Interest Coverage | - | - | - | -101.20x | -30.05x | -19.62x | -21.15x | -8.43x | -1.63x | -2.40x |
FCF Conversion | 0.74x | 0.78x | 0.64x | 0.88x | 0.82x | 0.90x | 0.91x | 1.25x | 1.29x | 1.81x |
Revenue Growth | -82.72% | 0.09% | -56.85% | -45% | 450.59% | -57.21% | -60.23% | 32386.92% | 138.83% | 68.64% |
Related:GERN Dividend History·GERN Revenue History·GERN Price History·GERN P/E History·GERN Financial Ratios·GERN Institutional Holders
GERN SEC Filings & Documents
Geron Corporation (GERN) SEC filings — annual & quarterly reports (10-K, 10-Q)
GERN Frequently Asked Questions
Geron Corporation (GERN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Geron Corporation (GERN) reported $196.1M in revenue for fiscal year 2025. This represents a 3600% increase from $5.3M in 1996.
Geron Corporation (GERN) grew revenue by 138.8% over the past year. This is strong growth.
Geron Corporation (GERN) reported a net loss of $69.6M for fiscal year 2025.
Dividend & Returns
Geron Corporation (GERN) has a return on equity (ROE) of -33.9%. Negative ROE indicates the company is unprofitable.
Geron Corporation (GERN) had negative free cash flow of $126.3M in fiscal year 2025, likely due to heavy capital investments.